1. Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy
   Anika Nagelkerke et al, 2015, Seminars in Cancer Biology CrossRef
2. Autophagy-Related Deubiquitinating Enzymes Involved in Health and Disease
   Fouzi Magraoui et al, 2015, Cells CrossRef
3. Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models
   Alexandre Parks et al, 2015 CrossRef
4. Induction of Atypical Autophagy by Porcine Hemagglutinating Encephalomyelitis Virus Contributes to Viral Replication
   Ning Ding et al, 2017, Front. Cell. Infect. Microbiol. CrossRef
5. Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells
   Juan Liu et al, 2016, IJMS CrossRef
6. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.
   Cynthia I Chude et al, 2017, Int J Mol Sci CrossRef
7. Autophagy: The spotlight for cellular stress responses
   Palaniyandi Ravanan et al, 2017, Life Sciences CrossRef
8. HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration
   Congying Zhang et al, 2016, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
9. Regulation of the Tumor-Suppressor BECLIN 1 by Distinct Ubiquitination Cascades
   Fahd Boutouja et al, 2017, IJMS CrossRef
10. A role for autophagy in long-term spatial memory formation in male rodents
    Michael J. Hylin et al, 2017, J Neuro Res CrossRef
11. Design of Small Molecule Autophagy Modulators: A promising druggable strategy
    Siyu He et al, 2017, J. Med. Chem. CrossRef
12. TFAM is a novel mediator of immunogenic cancer cell death
    Minghua Yang et al, 2018, OncoImmunology CrossRef
13. Regulation of the Tumor-Suppressor Function of the Class III Phosphatidylinositol 3-Kinase Complex by Ubiquitin and SUMO
    Christina Reidick et al, 2014, Cancers CrossRef
14. Inflachromene inhibits autophagy through modulation of Beclin 1 activity
    Young Hun Kim et al, 2018, J Cell Sci CrossRef
15. Simultaneous induction and blockade of autophagy by a single agent
    Karolina Kucharewicz et al, 2018, Cell Death Dis CrossRef
16. Targeting autophagy in cancer.
    Angelique V Onorati et al, 2018, Cancer CrossRef
17. Autophagy Inhibition and Chemosensitization in Cancer Therapy
    Emmanuel K. Cudjoe et al, 2019 CrossRef
18. Hormone-dependent breast cancer: Targeting autophagy and PI3K overcomes Exemestane-acquired resistance
    Cristina Amaral et al, 2018, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
19. Autophagy in cancer: a complex relationship
    Lindsay Wilde et al, 2018, Biochem. J. CrossRef
20. The Implication of Cancer Progenitor Cells and the Role of Epigenetics in the Development of Novel Therapeutic Strategies for Chronic Myeloid Leukemia
    Stephanie M. Tortorella et al, 2015, Antioxidants & Redox Signaling CrossRef
21. The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells
    Courtney R. Schott et al, 2018, PLoS ONE CrossRef
22. The Roles of Autophagy in Cancer.
    Sang hun Lee, 0 CrossRef
23. Tricyclic antidepressant amitriptyline inhibits autophagic flux and prevents tube formation in vascular endothelial cells
    Yinglu Guan et al, 2018, Basic Clin Pharmacol Toxicol CrossRef
24. Autophagy in Cancer: Regulation by Small Molecules
    Allison S. Limpert et al, 2018, Trends in Pharmacological Sciences CrossRef
25. Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
    Katharina Rothe et al, 2019, IJMS CrossRef
26. Chemical Screening Approaches Enabling Drug Discovery of Autophagy Modulators for Biomedical Applications in Human Diseases
    Prashanta Kumar Panda et al, 2019, Front. Cell Dev. Biol. CrossRef
27. Autophagy as a molecular target for cancer treatment.
    Nur Mehpare Kocaturk et al, 2019, Eur J Pharm Sci CrossRef
28. Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
    Yuning Liao et al, 2019, J Exp Clin Cancer Res CrossRef
29. ROS inhibit autophagy by downregulating ULK1 mediated by the phosphorylation of p53 in selenite-treated NB4 cells
    Y Ci et al, 2014, Cell Death Dis CrossRef
30. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes
    Xin Gu et al, 2016, Cell Death Dis CrossRef
31. Cell death: a review of the major forms of apoptosis, necrosis and autophagy.
    Mark S D'Arcy, 2019, Cell Biol Int CrossRef
32. USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
    Yuning Liao et al, 2019, Cell Discov CrossRef
33. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
    Smruthi Vijayaraghavan et al, 2017, Nat Commun CrossRef
34. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis
    Huayao Li et al, 2019, Mol Genet Genomic Med CrossRef
35. Inducing mitophagy in diabetic platelets protects against severe oxidative stress
    Seung Hee Lee et al, 2016, EMBO Mol Med CrossRef
36. Chloroquine and hydroxychloroquine for cancer therapy
    Gwenola Manic et al, 2014, Molecular & Cellular Oncology CrossRef
37. Pro-survival Autophagy: An Emerging Candidate of Tumor Progression through Maintaining Hallmarks of Cancer
    Chandan Kanta Das et al, 2019, Seminars in Cancer Biology CrossRef
38. Autophagy as a Mechanism for Anti-Angiogenic Therapy Resistance
    Ankush Chandra et al, 2019, Seminars in Cancer Biology CrossRef
39. Autophagy inhibitors.
    Benoit Pasquier, 0 CrossRef
40. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents.
    Cheng Wang et al, 2016, Pharmacol Res CrossRef
41. Novel pharmacological modulators of autophagy: an updated patent review (2012-2015)
    Joohun Ha et al, 2016, Expert Opinion on Therapeutic Patents CrossRef
42. Autophagy Inhibition as a Strategy for Cancer Therapy
    Xiaohong Ma et al, 2016 CrossRef
43. Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells
    Malgorzata Kucinska et al, 2016, Toxicology in Vitro CrossRef
44. Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity
    Dayton M. Petibone et al, 2017, J. Appl. Toxicol. CrossRef
45. GSK-3 as a novel prognostic indicator in leukemia
    Peter P. Ruvolo, 2017, Advances in Biological Regulation CrossRef
46. Spautin-A41 Attenuates Cerulein-Induced Acute Pancreatitis through Inhibition of Dysregulated Autophagy
    Kai Dong et al, 2019, Biological & Pharmaceutical Bulletin CrossRef
47. Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
    Fabien Muselli et al, 2019, IJMS CrossRef
48. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
    Cally J. Ho et al, 2019, Cancers CrossRef
49. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
    Tuhina Khan et al, 2019, Med Res Rev CrossRef
50. A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299
    Lucie Cechakova et al, 2019, IJMS CrossRef
51. Autophagy-regulating N-heterocycles derivatives as potential anticancer agents
    Xiaoxia Liang et al, 2019, Future Medicinal Chemistry CrossRef
52. Regulation of Autophagy Is a Novel Tumorigenesis-Related Activity of Multifunctional Translationally Controlled Tumor Protein
    Ji-Sun Lee et al, 2020, Cells CrossRef
53. Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin
    Jia Guo et al, 2020, J Cell Mol Med CrossRef
54. DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer
    Xiang-ling Chen et al, 2020, Acta Pharmacol Sin CrossRef
55. Autophagy and Tumour Stem Cells
    Xue Yang et al, 2020 CrossRef
56. Autophagy in Osteosarcoma.
    Grace Nehme et al, 2020, Adv Exp Med Biol CrossRef
57. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy
    Liudmila V. Spirina et al, 2020, CDT CrossRef
58. The Role of Autophagy in Targeted Therapy for Acute Myeloid Leukemia
    Wenxin Du et al, 2020, Autophagy CrossRef
59. Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage
    Javier Chicote et al, 2020, Front. Pharmacol. CrossRef
60. Relevance of Autophagy in Cancer Stem Cell and Therapeutic
    Niharika Sinha, 2020 CrossRef
61. Autophagy: An Agonist and Antagonist with an Interlink of Apoptosis in Cancer
    Vanishri Chandrashekhar Haragannavar et al, 2020 CrossRef
62. Human Cytomegalovirus-Induced Autophagy Prevents Necroptosis of Infected Monocytes
    Aaron M. Altman et al, 2020, J Virol CrossRef
63. Assessing methods to quantitatively validate TGFβ-dependent autophagy
    Charles B. Trelford et al, 2020, Biology Open CrossRef
64. When the chains do not break: the role of USP10 in physiology and pathology
    Udayan Bhattacharya et al, 2020, Cell Death Dis CrossRef
65. Taming the Autophagy as a Strategy for Treating COVID-19
    Blanca Estela García-Pérez et al, 2020, Cells CrossRef
66. Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
    Valentina R. Minciacchi et al, 2021, Cells CrossRef
67. Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies.
    Malina Xiao et al, 2021, Front Oncol CrossRef
68. Application of ZnO/CNT@Fe3O4 nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia
    Amir-Mohammad Yousefi et al, 2021, Biomed. Mater. CrossRef
69. Autophagy and senescence in cancer therapy
    Nipa H. Patel et al, 2021 CrossRef
70. Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer.
    Xin Chien Lee et al, 2021, Cancers (Basel) CrossRef
71. First insights into the autophagy machinery of adult Schistosoma mansoni
    Mudassar N. Mughal et al, 2021, International Journal for Parasitology CrossRef
72. Macrophages at Low-Inflammatory Status Improved Osteogenesis via Autophagy Regulation
    Lan Yang et al, 2021, Tissue Engineering Part A CrossRef
73. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2
    Hengyue Shan et al, 2021, Cell Chemical Biology CrossRef
74. Ferritinophagy and ferroptosis in the management of metabolic diseases
    Amir Ajoolabady et al, 2021, Trends in Endocrinology & Metabolism CrossRef
75. Autophagy Modulators in Cancer Therapy.
    Agnieszka Gornowicz, 0 CrossRef
76. Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.
    Sofia Papanikolaou et al, 2021, Cancers (Basel) CrossRef
77. Autophagy Does Not Contribute to TKI Response in a Imatinib-Resistant Chronic Myeloid Leukemia Cell Line
    S. Baykal-Köse et al, 2021, Mol Biol CrossRef
78. Deubiquitinases in hematological malignancies
    Hu Lei et al, 2021, Biomark Res CrossRef
79. Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology
    Xiaoguang Liu et al, 2021, Metabolites CrossRef
80. Crosslink between p53 and metastasis: focus on epithelial–mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis
    Ghader Babaei et al, 2021, Mol Biol Rep CrossRef
81. Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
    Alexander G. Raufi et al, 2021, Front. Pharmacol. CrossRef
82. Unraveling and targeting RAS-driven metabolic signaling for therapeutic gain
    Jonathan M. DeLiberty et al, 2022 CrossRef
83. Beclin1-mediated interplay between autophagy and apoptosis: New understanding
    Kumari Prerna et al, 2022, International Journal of Biological Macromolecules CrossRef
84. 4‑Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine‑resistant pancreatic cancer cells
    Ying-Yin Chen et al, 2022, Oncol Lett CrossRef
85. The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics
    Qiong Li et al, 2022, Cell Death Dis CrossRef
86. Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers
    Abdul Alim Al-Bari, 2022, All Life CrossRef
87. The inhibition of autophagy by spautin boosts the anticancer activity of fingolimod in multidrug-resistant hepatocellular carcinoma
    Dima W. Alhamad et al, 2022, Life Sciences CrossRef
88. Discovery of fused benzimidazole-imidazole autophagic flux inhibitors for treatment of triple-negative breast cancer
    Dong-Lin Yang et al, 2022, European Journal of Medicinal Chemistry CrossRef
89. Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation
    Kazuhiro Kunimasa et al, 2022, Sci Rep CrossRef
90. Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
    Josef Gillson et al, 2022, Cancers CrossRef
91. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
    Yuan-Yuan Yong et al, 2022, Clinical Immunology CrossRef
92. Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
    Lijuan Zhang et al, 2022, Front. Pharmacol. CrossRef
93. Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses
    Qinqin Sun et al, 2022, Autophagy CrossRef
94. Protein Quality Control in Glioblastoma: A Review of the Current Literature with New Perspectives on Therapeutic Targets
    Angela Rocchi et al, 2022, IJMS CrossRef
95. Autophagy in Cancer Cell Transformation: A Potential Novel Therapeutic Strategy
    Basheer Abdullah Marzoog, 2022, CCDT CrossRef
96. Tumor cell metabolism and autophagy as therapeutic targets
    Satish S. Poojary et al, 2022 CrossRef
97. Polymeric Chloroquine as an Effective Antimigration Agent in the Treatment of Pancreatic Cancer
    Rubayat Khan et al, 2022, Mol. Pharmaceutics CrossRef
98. Targeting MCL-1 in hematologic malignancies: Rationale and progress
    Andrew H. Wei et al, 2020, Blood Reviews CrossRef
99. Second generation Spautin-1 analogues targeting EGFR-mutant non-small cell lung cancer cells
    Mathias Elsocht et al, 2022, Bioorganic & Medicinal Chemistry Letters CrossRef
100. Spautin-1 Protects Against Mild TBI-Induced Anxiety-Like Behavior in Mice via Immunologically Silent Apoptosis
     Hui-Tao Miao et al, 2023, Neuromol Med CrossRef
101. Long non-coding RNA LINC01559 exerts oncogenic role via enhancing autophagy in lung adenocarcinoma.
     Zhuochen Zhao et al, 2021, Cancer Cell Int CrossRef
102. Discovery of Fused Benzimidazole-Imidazole Autophagic Flux Inhibitors for Treatment of Triple-Negative Breast Cancer
     Dong-Lin Yang et al, 2022, SSRN Journal CrossRef
103. Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds
     Yuan Liu et al, 2023, European Journal of Medicinal Chemistry CrossRef
104. A review of deubiquitinases and thier roles in tumorigenesis and development
     Xian-Wen Liang et al, 2023, Front. Bioeng. Biotechnol. CrossRef
105. Identification of natural compound garcinone E as a novel autophagic flux inhibitor with anticancer effect in nasopharyngeal carcinoma cells
     Dan Wei et al, 2023, Pharmaceutical Biology CrossRef
106. Autophagy induced by Helicobacter Pylori infection can lead to gastric cancer dormancy, metastasis, and recurrence: new insights
     Abdullatif Akbari et al, 2023, Human Cell CrossRef
107. Unveiling autophagy complexity in leukemia: The molecular landscape and possible interactions with apoptosis and ferroptosis
     Young Yun Jung et al, 2023, Cancer Letters CrossRef
108. Targeting autophagy drug discovery: Targets, indications and development trends
     Mengjia Jiang et al, 2024, European Journal of Medicinal Chemistry CrossRef
109. The multiple roles of autophagy in uveal melanoma and the microenvironment
     Bo Liu et al, 2024, J Cancer Res Clin Oncol CrossRef
110. Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells
     Sara M. Elgendy et al, 2024, IUBMB Life CrossRef
111. The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.
     Swathi V. Kona et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
112. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review
     Ahmed Mostafa Ibrahim Abdelrahman Hassan et al, 2024, IJMS CrossRef
113. Emerging Role of Autophagy in the Development and Progression of Oral Squamous Cell Carcinoma
     Yomna S. Abd El-Aziz et al, 2021, Cancers CrossRef
114. USP10 as a Potential Therapeutic Target in Human Cancers
     Li Tao et al, 2022, Genes CrossRef
115. Novel Effects of Statins on Cancer via Autophagy
     Daniela Mengual et al, 2022, Pharmaceuticals CrossRef
116. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?
     Ahmed M. Elshazly et al, 2024, Cancers CrossRef
117. Anti-Cancer Strategy Based on Changes in the Role of Autophagy Depending on the Survival Environment and Tumorigenesis Stages
     Michael Lee et al, 2024, Molecules CrossRef
118. Switching between autophagy and apoptosis prosurvival and prodeath balance in leukemia cells
     Peter Racay, 2025 CrossRef
119. DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
     Biying Qin et al, 2024, Cell Death Discov. CrossRef